{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:14:05Z","timestamp":1792502045561,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ygyno.2013.12.028","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T09:12:58Z","timestamp":1388740378000},"page":"303-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series"],"prefix":"10.1016","volume":"132","clinical-trial-number":[{"clinical-trial-number":"nct01539785","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01588964","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"A.","family":"Fagotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chiantera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2013.12.028_bb0005","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2013.06.020","article-title":"Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors","volume":"131","author":"Petrillo","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2013.01.015","article-title":"Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy","volume":"129","author":"Magrina","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case\u2013control study on survival in patients with two year follow-up","volume":"127","author":"Fagotti","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0030","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1245\/s10434-012-2510-4","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients","volume":"19","author":"Bakrin","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.028_bb0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2005.06.043","article-title":"Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study","volume":"99","author":"Ferron","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/SLA.0b013e31820784df","article-title":"Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience","volume":"253","author":"Esquivel","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome","volume":"122","author":"Fagotti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000159266","article-title":"A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy","volume":"75","author":"Fagotti","year":"2008","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1245\/s10434-007-9571-9","article-title":"Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study","volume":"15","author":"Gesson-Paute","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0065","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1245\/s10434-008-0115-8","article-title":"Increased tissue diffusion of oxaliplatin during laparoscopically assisted versus open heated intraoperative intraperitoneal chemotherapy (HIPEC)","volume":"15","author":"Thomas","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","article-title":"High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis","volume":"244","author":"Esquis","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ygyno.2013.12.028_bb0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","article-title":"Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration","volume":"7","author":"Jacquet","year":"1996","journal-title":"Anticancer Drugs"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813013929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813013929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T15:20:46Z","timestamp":1538925646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813013929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0090825813013929"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}